Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amgen Files Osteoporosis Drug In US Ahead Of Rival Merck

Jul 22 2016

• By Lucie Ellis-Taitt

Osteoporosis

Related Content

Positive Data For Amgen/UCB's Romosozumab In Men With Osteoporosis

Mar 22 2016

Amgen/UCB Poised For Osteoporosis Drug Filing On Back Of Mixed PhIII

Feb 23 2016

Related Companies

Amgen, Inc.

UCB S.A.

Mereo BioPharma Group plc

Eli Lilly and Company

Merck & Co., Inc.

Radius Health, Inc.

Tarsa Therapeutics, Inc.

Additional Topics

Commercial Biologics Business Strategies Market Intelligence BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.